Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings

Diletta Valentini, Valentina Marcellini, Simona Bianchi, Alberto Villani, Marzia Facchini, Isabella Donatelli, Maria Rita Castrucci, Emiliano Marasco, Chiara Farroni, Rita Carsetti

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: Immunodeficiency is an integral aspect of Down syndrome, as demonstrated by the increased susceptibility to infection of affected. Mortality is still higher than in general population, with respiratory infections among the major causes of death. As more people with Down syndrome are living today than ever before, it is indispensable to develop strategies to prevent and cure the associated disorders. Vaccination is the most successful instrument of preventive medicine. Special seasonal influenza and pneumococcal vaccination strategies have been designed for individuals with risk conditions of all ages. Down syndrome individuals are not included in the high-risk categories. Methods: We enrolled in our study 15 children with Down syndrome and their siblings, vaccinated for the first time with seasonal influenza vaccine and receiving a booster dose of a glyco-conjugated pneumococcal vaccine. We compared the immunological features and response to vaccination measuring serum antibody titers and frequency of specific memory B cells. Results: We confirm that a severe reduction of switched memory B cells is always associated to Down syndrome. After primary vaccination Down syndrome children generate significantly less specific switched memory B cells than their siblings. The response to a booster dose of vaccine is instead comparable in both groups. The production of specific antibodies was equally effective in Down syndrome and controls both after primary and secondary immunization. Conclusions: Down syndrome individuals should be considered a high risk group, because of their increased susceptibility to infection and reduced number of switched memory B cells. Tailored vaccination protocols are needed in order to reduce their burden of infections throughout life.

Original languageEnglish
Pages (from-to)6689-6696
Number of pages8
JournalVaccine
Volume33
Issue number48
DOIs
Publication statusPublished - Nov 27 2015

Fingerprint

Down syndrome
Down Syndrome
B-lymphocytes
Siblings
Vaccination
B-Lymphocytes
vaccination
vaccines
influenza
infection
Infection
Secondary Immunization
Pneumococcal Vaccines
Preventive Medicine
antibodies
risk groups
Influenza Vaccines
immunosuppression
dosage
Respiratory Tract Infections

Keywords

  • Antibodies
  • Down syndrome
  • Respiratory infections
  • Switched memory B cells
  • Vaccination

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings. / Valentini, Diletta; Marcellini, Valentina; Bianchi, Simona; Villani, Alberto; Facchini, Marzia; Donatelli, Isabella; Castrucci, Maria Rita; Marasco, Emiliano; Farroni, Chiara; Carsetti, Rita.

In: Vaccine, Vol. 33, No. 48, 27.11.2015, p. 6689-6696.

Research output: Contribution to journalArticle

Valentini, D, Marcellini, V, Bianchi, S, Villani, A, Facchini, M, Donatelli, I, Castrucci, MR, Marasco, E, Farroni, C & Carsetti, R 2015, 'Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings', Vaccine, vol. 33, no. 48, pp. 6689-6696. https://doi.org/10.1016/j.vaccine.2015.10.083
Valentini, Diletta ; Marcellini, Valentina ; Bianchi, Simona ; Villani, Alberto ; Facchini, Marzia ; Donatelli, Isabella ; Castrucci, Maria Rita ; Marasco, Emiliano ; Farroni, Chiara ; Carsetti, Rita. / Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings. In: Vaccine. 2015 ; Vol. 33, No. 48. pp. 6689-6696.
@article{883ac2120a1b4795b8d3735c983cfe42,
title = "Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings",
abstract = "Background: Immunodeficiency is an integral aspect of Down syndrome, as demonstrated by the increased susceptibility to infection of affected. Mortality is still higher than in general population, with respiratory infections among the major causes of death. As more people with Down syndrome are living today than ever before, it is indispensable to develop strategies to prevent and cure the associated disorders. Vaccination is the most successful instrument of preventive medicine. Special seasonal influenza and pneumococcal vaccination strategies have been designed for individuals with risk conditions of all ages. Down syndrome individuals are not included in the high-risk categories. Methods: We enrolled in our study 15 children with Down syndrome and their siblings, vaccinated for the first time with seasonal influenza vaccine and receiving a booster dose of a glyco-conjugated pneumococcal vaccine. We compared the immunological features and response to vaccination measuring serum antibody titers and frequency of specific memory B cells. Results: We confirm that a severe reduction of switched memory B cells is always associated to Down syndrome. After primary vaccination Down syndrome children generate significantly less specific switched memory B cells than their siblings. The response to a booster dose of vaccine is instead comparable in both groups. The production of specific antibodies was equally effective in Down syndrome and controls both after primary and secondary immunization. Conclusions: Down syndrome individuals should be considered a high risk group, because of their increased susceptibility to infection and reduced number of switched memory B cells. Tailored vaccination protocols are needed in order to reduce their burden of infections throughout life.",
keywords = "Antibodies, Down syndrome, Respiratory infections, Switched memory B cells, Vaccination",
author = "Diletta Valentini and Valentina Marcellini and Simona Bianchi and Alberto Villani and Marzia Facchini and Isabella Donatelli and Castrucci, {Maria Rita} and Emiliano Marasco and Chiara Farroni and Rita Carsetti",
year = "2015",
month = "11",
day = "27",
doi = "10.1016/j.vaccine.2015.10.083",
language = "English",
volume = "33",
pages = "6689--6696",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "48",

}

TY - JOUR

T1 - Generation of switched memory B cells in response to vaccination in Down syndrome children and their siblings

AU - Valentini, Diletta

AU - Marcellini, Valentina

AU - Bianchi, Simona

AU - Villani, Alberto

AU - Facchini, Marzia

AU - Donatelli, Isabella

AU - Castrucci, Maria Rita

AU - Marasco, Emiliano

AU - Farroni, Chiara

AU - Carsetti, Rita

PY - 2015/11/27

Y1 - 2015/11/27

N2 - Background: Immunodeficiency is an integral aspect of Down syndrome, as demonstrated by the increased susceptibility to infection of affected. Mortality is still higher than in general population, with respiratory infections among the major causes of death. As more people with Down syndrome are living today than ever before, it is indispensable to develop strategies to prevent and cure the associated disorders. Vaccination is the most successful instrument of preventive medicine. Special seasonal influenza and pneumococcal vaccination strategies have been designed for individuals with risk conditions of all ages. Down syndrome individuals are not included in the high-risk categories. Methods: We enrolled in our study 15 children with Down syndrome and their siblings, vaccinated for the first time with seasonal influenza vaccine and receiving a booster dose of a glyco-conjugated pneumococcal vaccine. We compared the immunological features and response to vaccination measuring serum antibody titers and frequency of specific memory B cells. Results: We confirm that a severe reduction of switched memory B cells is always associated to Down syndrome. After primary vaccination Down syndrome children generate significantly less specific switched memory B cells than their siblings. The response to a booster dose of vaccine is instead comparable in both groups. The production of specific antibodies was equally effective in Down syndrome and controls both after primary and secondary immunization. Conclusions: Down syndrome individuals should be considered a high risk group, because of their increased susceptibility to infection and reduced number of switched memory B cells. Tailored vaccination protocols are needed in order to reduce their burden of infections throughout life.

AB - Background: Immunodeficiency is an integral aspect of Down syndrome, as demonstrated by the increased susceptibility to infection of affected. Mortality is still higher than in general population, with respiratory infections among the major causes of death. As more people with Down syndrome are living today than ever before, it is indispensable to develop strategies to prevent and cure the associated disorders. Vaccination is the most successful instrument of preventive medicine. Special seasonal influenza and pneumococcal vaccination strategies have been designed for individuals with risk conditions of all ages. Down syndrome individuals are not included in the high-risk categories. Methods: We enrolled in our study 15 children with Down syndrome and their siblings, vaccinated for the first time with seasonal influenza vaccine and receiving a booster dose of a glyco-conjugated pneumococcal vaccine. We compared the immunological features and response to vaccination measuring serum antibody titers and frequency of specific memory B cells. Results: We confirm that a severe reduction of switched memory B cells is always associated to Down syndrome. After primary vaccination Down syndrome children generate significantly less specific switched memory B cells than their siblings. The response to a booster dose of vaccine is instead comparable in both groups. The production of specific antibodies was equally effective in Down syndrome and controls both after primary and secondary immunization. Conclusions: Down syndrome individuals should be considered a high risk group, because of their increased susceptibility to infection and reduced number of switched memory B cells. Tailored vaccination protocols are needed in order to reduce their burden of infections throughout life.

KW - Antibodies

KW - Down syndrome

KW - Respiratory infections

KW - Switched memory B cells

KW - Vaccination

UR - http://www.scopus.com/inward/record.url?scp=84951567937&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84951567937&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2015.10.083

DO - 10.1016/j.vaccine.2015.10.083

M3 - Article

VL - 33

SP - 6689

EP - 6696

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 48

ER -